Document Detail


Primary cutaneous aspergillosis (PCA)--a case report.
MedLine Citation:
PMID:  16188782     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSION: After having treated this patient successfully and having gone through the available literature, we conclude that treating primary cutaneous aspergillosis with intravenous amphotericin B prevents disseminated aspergillosis and is the treatment of choice.
Authors:
Jannicke Andresen; Egil André Nygaard; Ketil Størdal
Publication Detail:
Type:  Case Reports; Journal Article; Twin Study    
Journal Detail:
Title:  Acta paediatrica (Oslo, Norway : 1992)     Volume:  94     ISSN:  0803-5253     ISO Abbreviation:  Acta Paediatr.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-09-28     Completed Date:  2005-10-14     Revised Date:  2014-07-29    
Medline Journal Info:
Nlm Unique ID:  9205968     Medline TA:  Acta Paediatr     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  761-2     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amphotericin B / administration & dosage
Aspergillosis / drug therapy*
Dermatomycoses / drug therapy*
Diseases in Twins / drug therapy*
Humans
Infant, Newborn
Infant, Premature, Diseases / drug therapy*
Male
Chemical
Reg. No./Substance:
7XU7A7DROE/Amphotericin B

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aplasia cutis congenita of the scalp: how much therapy is necessary in large defects?
Next Document:  Streptococcal toxic shock syndrome in children without skin and soft tissue infection: report of fou...